Ascentage Pharma Group International (HKG:6855)
Hong Kong · Delayed Price · Currency is HKD 45.96
+3.20 (7.48%)
At close: Mar 27, 2026
HKG:6855 Market Cap
HKG:6855 has a market cap or net worth of 15.74 billion as of March 27, 2026. Its market cap has increased by 19.77% in one year.
Market Cap
15.74B
Enterprise Value
15.20B
Revenue
638.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
45.96
Market Cap Chart
Since October 28, 2019, HKG:6855's market cap has increased from 7.59B to 15.74B, an increase of 107.41%. That is a compound annual growth rate of 12.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 15.74B | -18.16% |
| Dec 31, 2025 | 19.23B | 36.66% |
| Dec 31, 2024 | 14.07B | 81.16% |
| Dec 29, 2023 | 7.77B | 17.12% |
| Dec 30, 2022 | 6.63B | -8.70% |
| Dec 31, 2021 | 7.26B | -14.53% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InnoCare Pharma | 25.02B |
| Genscript Biotech | 24.07B |
| Duality Biotherapeutics | 23.72B |
| PegBio | 23.00B |
| Keymed Biosciences | 16.98B |
| Zai Lab | 16.02B |
| Ascletis Pharma | 15.32B |
| Nanjing Leads Biolabs | 13.67B |